Need a #PDF of the complete #HRS2023 program for registration or travel approvals? You're in luck! A complimentary PDF of the full educational program is now available on https://t.co/CU50FvvNu7 for prospective & registered attendees. #EPeeps
DOWNLOAD > https://t.co/tRgZ8fbWR9
Join @WomenHeartOrg & @MendedHearts for a free webinar discussing what you need to know about #AFib on April 20 at 2 pm ET.
Learn more and register now: https://t.co/ZnnZR0CpZE
High incidence of #AFib in women after a breast #cancer diagnosis.
New-onset #AF in the new breast cancer diagnosis increases 1-year cardiovascular mortality
A SEER-Medicare analysis https://t.co/FK6DphtPr0
"Trials studying BTK inhibitors, which are associated with an increased risk of AF, should consider implementation of a standardized AF detection strategy." @CardioOncoCaen@md_addison#cardiooncology#Afib https://t.co/35eMQdxNtv
It’s #WorldHealthDay and WHO’s 75th anniversary! An opportunity to look back at the achievements of #Afib research empowering physicians and patients through greater knowledge and more personalized therapies. Let´s continue to collaborate to improve the quality of healthcare.
It seems we’re always learning something new about #AFib. Research published in EP #Europace suggests inflammatory autoimmune diseases are associated with new-onset AF, with higher incidence in women.
Review the data: https://t.co/W11faYSXLl
"It was so easy. It was light, comfortable…it wasn’t big and bulky….I didn't have to carry a separate cellphone." Part 4: Receiving the RhythmStar #cardiac monitor
https://t.co/ixZebxLrH0
#PatientCare#electrophysiology#Cardiology#ECG
#AtrialFibrillation (also called #AFib) is a common condition in which the heart beats irregularly. Read more in our blog https://t.co/TJeu3psX3I #SimpleScience
@DAICeditor@insightpartners The #AFib market is expected to grow at a CAGR of 14.11% from 2022 to 2028, attributed to the increasing prevalence of #atrial_fibrillation and rising awareness regarding atrial fibrillation: https://t.co/0iANpIht1T
@DAICeditor@insightpartners The #AFib market is expected to grow at a CAGR of 14.11% from 2022 to 2028, attributed to the increasing prevalence of #atrial_fibrillation and rising awareness regarding atrial fibrillation: https://t.co/0iANpIht1T
📍 Can symptoms of atrial fibrillation overlap with other conditions? Follow a patient’s journey with expert guidance. #CME#AFib#MedEd#MedTwitter
📝 https://t.co/3vbYgxf7pL
"I had been to the doctor's office off and on for 3 yrs...my heart was always 'fine'. Not only was I frustrated but so were my doctors." Listen to Part 3: Pathway to #diagnosis.
https://t.co/2S4z1xGMT3
#patientexperience#hearthealthawareness#cardiotwitter
An early rhythm control strategy for treatment of #AFib was cost-effective in a German population, data from EAST-AFNET 4 - #EPeeps https://t.co/ApTKphMioU
📍 Can symptoms of atrial fibrillation overlap with other conditions? Follow a patient’s journey with expert guidance. #CME#AFib#MedEd#MedTwitter
📝 https://t.co/aN8Yy0AO9B
Pulmonary vein isolation is successful in most patients undergoing #AFib ablation, according to a study in #JACC. Read more about the new findings with @HealthDayTweets: https://t.co/reBax2vNDB #epAblation
Insightful @npjDigitalMed publication re: use of #WearableTech to assess effects of hourly air pollutants and #AFib onset.
Check out the data: https://t.co/yA0Sp2r2qD…